Xanadu Mines Limited (ASX:XAM) Receives $0.08 Cash Takeover Offer from Bastion Mining
Xanadu Mines Limited (ASX:XAM) receives a $0.08 cash takeover offer from Bastion Mining, emphasizing a significant premium and strategic changes.
Category: Companies
Imugene Limited (ASX:IMU) Announces Extraordinary General Meeting
Imugene Limited (ASX:IMU) announces an Extraordinary General Meeting to discuss share consolidation and the issuance of new shares to support its clinical projects.
Assetora Limited (ASX:AOH) Announces Launch of Australian Homeowner Equity Fund
Assetora Limited (ASX:AOH) launches the Australian Homeowner Equity Fund, providing a unique shared equity solution for investors and homeowners.
TerraCom Limited (ASX:TER) Reaches Agreement with ASIC on Whistleblower Proceedings
TerraCom Limited (ASX:TER) has settled ASIC whistleblower proceedings with a $7.5 million penalty, pending court approval.
DXN Limited (ASX:DXN) Secures A$2m Data Centre Contract with DP World Australia
DXN Limited (ASX:DXN) secures a A$2 million contract with DP World Australia to deliver modular data centres in New South Wales.
American West Metals Limited (ASX:AW1) Secures A$5.9M Equity Raising
American West Metals (ASX:AW1) successfully raises A$5.9M through equity placement to advance its Storm Copper Project.
Beacon Minerals Limited (ASX:BCN) Executes Wealth of Nations Option Agreement
Beacon Minerals Limited (ASX:BCN) acquires option for Wealth of Nations tenements, initiating a drilling program near its Jaurdi plant.
EROAD Limited (ASX:ERD) Announces FY25 Financial Results
EROAD Limited (ASX:ERD) reports a 6.8% revenue increase and substantial free cash flow improvement for FY25.
Horseshoe Metals Ltd (ASX:HOR) Recommissions Infrastructure at Horseshoe Lights
Horseshoe Metals Ltd (ASX:HOR) recommissions infrastructure at Horseshoe Lights to support DSO operations and Melody Gold’s processing activities.
Recce Pharmaceuticals (ASX:RCE) Secures China Patent for Anti-Infectives
Recce Pharmaceuticals (ASX:RCE) secures a China Patent for its RECCE® anti-infectives, enhancing its global intellectual property portfolio.